Top

Optie A:

Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
Optie B:

Deel de link per e-mail
Link delen

vorige artikel Social Anxiety in Parents of High-Functioning C...

volgende artikel A Parent-Mediated Intervention to Increase Resp...

Tip

Swipe om te navigeren naar een ander artikel

01-03-2013 | Original Paper | Uitgave 3/2013

Identification of Expanded Alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) Study

Tijdschrift:: Journal of Autism and Developmental Disorders > Uitgave 3/2013

Auteurs:: Flora Tassone, Nimrah S. Choudhary, Federica Tassone, Blythe Durbin-Johnson, Robin Hansen, Irva Hertz-Picciotto, Isaac Pessah

Extras

» Toegang tot de volledige tekst krijgen

Belangrijke opmerkingen

Electronic supplementary material

The online version of this article (doi:10.1007/s10803-012-1580-2) contains supplementary material, which is available to authorized users.

Abstract

Fragile X syndrome (FXS) is a neuro-developmental disorder characterized by intellectual disabilities and autism spectrum disorders (ASD). Expansion of a CGG trinucleotide repeat (>200 repeats) in the 5′UTR of the fragile X mental retardation gene, is the single most prevalent cause of cognitive disabilities. Several screening studies for FXS, among individuals with ID from different ethnic populations, have indicated that the prevalence of the syndrome varies between 0.5 and 16 %. Because the high co-morbidity with autism, we have conducted a screening study of the cohort from CHARGE, a large-scale, population-based, case control study. We have identified six subjects carrying an expanded allele, which emphasize the importance of screening for FXS in a population with intellectual disabilities and ASD.

Log in om toegang te krijgen

Hier inloggen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Met BSL Psychologie Totaal blijft u als professional steeds op de hoogte van de nieuwste ontwikkelingen binnen uw vak. Met het online abonnement heeft u toegang tot een groot aantal boeken, protocollen, vaktijdschriften en e-learnings op het gebied van psychologie en psychiatrie. Zo kunt u op uw gemak en wanneer het u het beste uitkomt verdiepen in uw vakgebied.

Meer informatie

Alleen toegankelijk voor geautoriseerde gebruikers

Aziz, M., Stathopulu, E., Callias, M., Taylor, C., Turk, J., Oostra, B., et al. (2003). Clinical features of boys with fragile X premutations and intermediate alleles. American Journal of Medical Genetics, 121B(1), 119–127. PubMedCrossRef

Bailey, A., Bolton, P., Butler, L., Le Couteur, A., Murphy, M., Scott, S., et al. (1993). Prevalence of the fragile X anomaly amongst autistic twins and singletons. J of Child Psychology and Psychiatry, 34(5), 673–688. CrossRef

Bailey, D. B., Jr, Hatton, D. D., Mesibov, G. B., Ament, N., & Skinner, M. (2000). Early development, temperament and functional impairment in autism and fragile X syndrome. Journal of Autism and Developmental Disorders, 30(1), 49–59. PubMedCrossRef

Bailey, D. B., Jr, Hatton, D. D., Skinner, M., & Mesibov, G. B. (2001). Autistic behavior, FMR1 protein, and developmental trajectories in young males with fragile X syndrome. Journal of Autism and Developmental Disorder, 31(2), 165–174. CrossRef

Bailey, D. B., Jr., Raspa, M., Olmsted, M., & Holiday, D. B. (2008). Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. American Journal of Medical Genetics, Part A, 146A(16), 2060–2069. CrossRef

Biancalana, V., Beldjord, C., Taillandier, A., Szpiro-Tapia, S., Cusin, V., Gerson, F., et al. (2004). Five years of molecular diagnosis of Fragile X syndrome (1997–2001): A collaborative study reporting 95 % of the activity in France. American Journal of Medical Genetics, 129A(3), 218–224. PubMedCrossRef

Blomquist, H. K., Bohman, M., Edvinsson, S. O., Gillberg, C., Gustavson, K. H., Holmgren, G., et al. (1985). Frequency of the fragile X syndrome in infantile autism: A Swedish multicenter study. Clinical Genetics, 27(2), 113–117. PubMedCrossRef

Bodega, B., Bione, S., Dalpra, L., Toniolo, D., Ornaghi, F., Vegetti, W., et al. (2006). Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Human Reproduction, 21(4), 952–957. PubMedCrossRef

Bourgeois, J. A., Coffey, S. M., Rivera, S. M., Hessl, D., Gane, L. W., Tassone, F., et al. (2009). A review of fragile X premutation disorders: Expanding the psychiatric perspective. Journal of Clinical Psychiatry, 70(6), 852–862. PubMedCrossRef

Bretherick, K. L., Fluker, M. R., & Robinson, W. P. (2005). FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Human Genetics, 117(4), 376–382. PubMedCrossRef

Brown, W. T., Jenkins, E. C., Cohen, I. L., Fisch, G. S., Wolf-Schein, E. G., Gross, A., et al. (1986). Fragile X and autism: A multicenter survey. American Journal of Medical Genetics, 23(1–2), 341–352. PubMedCrossRef

Chen, L., Hadd, A., Sah, S., Filipovic-Sadic, S., Krosting, J., Sekinger, E., et al. (2010). An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. Journal of Molecular Diagnostics, 12(5), 589–600. PubMedCrossRef

Chonchaiya, W., Au, J., Schneider, A., Hessl, D., Harris, S. W., Laird, M., Mu, Y., Tassone, F., Nguyen, D. V., & Hagerman, R. J. (2012). Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Human Genetics, 131(4), 581–589. doi: 10.1007/s00439-011-1106-6 PubMedCrossRef

Clifford, S., Dissanayake, C., Bui, Q. M., Huggins, R., Taylor, A. K., & Loesch, D. Z. (2007). Autism spectrum phenotype in males and females with fragile X full mutation and premutation. Journal of Autism and Developmental Disorders, 37(4), 738–747. PubMedCrossRef

Cronister, A., Schreiner, R., Wittenberger, M., Amiri, K., Harris, K., & Hagerman, R. J. (1991). Heterozygous fragile X female: Historical, physical, cognitive, and cytogenetic features. American Journal of Medical Genetics, 38(2–3), 269–274. PubMedCrossRef

de Vries, B. B., Mohkamsing, S., van den Ouweland, A. M., Halley, D. J., Niermeijer, M. F., Oostra, B. A., et al. (1998). Screening with the FMR1 protein test among mentally retarded males. Human Genetics, 103(4), 520–522. PubMedCrossRef

de Vries, B. B., van den Ouweland, A. M., Mohkamsing, S., Duivenvoorden, H. J., Mol, E., Gelsema, K., et al. (1997). Screening and diagnosis for the fragile X syndrome among the mentally retarded: An epidemiological and psychological survey. Collaborative Fragile X Study Group. American Journal of Human Genetics, 61(3), 660–667. PubMedCrossRef

Dombrowski, C., Levesque, M. L., Morel, M. L., Rouillard, P., Morgan, K., & Rousseau, F. (2002). Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Human Molecular Genetics, 11(4), 371–378. PubMedCrossRef

Farzin, F., Perry, H., Hessl, D., Loesch, D., Cohen, J., Bacalman, S., et al. (2006). Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. Journal of Developmental and Behavioral Pediatrics, 27(2 Suppl), S137–S144. PubMedCrossRef

Fatemi, S. H., & Folsom, T. D. (2011). The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology, 60(7–8), 1221–1226. PubMedCrossRef

Fatemi, S. H., Kneeland, R. E., Liesch, S. B., & Folsom, T. D. (2010). Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizophrenia Research, 124(1–3), 246–247. PubMedCrossRef

Fernandez-Carvajal, I., Walichiewicz, P., Xiaosen, X., Pan, R., Hagerman, P. J., & Tassone, F. (2009). Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. Journal of Molecular Diagnostics, 11(4), 324–329. PubMedCrossRef

Filipovic-Sadic, S., Sah, S., Chen, L., Krosting, J., Sekinger, E., Zhang, W., et al. (2010). A novel FMR1 PCR method for the routine detection of low-abundance expanded alleles and full mutations in fragile X syndrome. Clinical Chemistry, 56(3), 399–408. PubMed

Fu, Y. H., Kuhl, D. P., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., et al. (1991). Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell, 67(6), 1047–1058. PubMedCrossRef

Garcia-Nonell, C., Ratera, E. R., Harris, S., Hessl, D., Ono, M. Y., Tartaglia, N., et al. (2008). Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. American Journal of Medical Genetics, Part A, 146A(15), 1911–1916. CrossRef

Haddad, L. A., Aguiar, M. J., Costa, S. S., Mingroni-Netto, R. C., Vianna-Morgante, A. M., & Pena, S. D. (1999). Fully mutated and gray-zone FRAXA alleles in Brazilian mentally retarded boys. American Journal of Medical Genetics, 84(3), 198–201. PubMedCrossRef

Hagerman, P. J. (2002). Gene expression and molecular approaches to therapy. In R. J. Hagerman & P. J. Hagerman (Eds.), Fragile X syndrome: Diagnosis, treatment and research (3rd ed.). Baltimore, MD: The Johns Hopkins University Press.

Hagerman, R. J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., et al. (2001). Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 57, 127–130. PubMedCrossRef

Hagerman, R. J., Rivera, S. M., & Hagerman, P. J. (2008). The fragile X family of disorders: A model for autism and targeted treatments. Current Pediatric Reviews, 4, 40–52. CrossRef

Hall, D. A., Berry-Kravis, E., Zhang, W., Tassone, F., Spector, E., Zerbe, G., et al. (2011). FMR1 gray-zone alleles: association with Parkinson’s disease in women? Movement Disorders: Official Journal of the Movement Disorder Society, 26(10), 1900–1906. CrossRef

Harris, S. W., Hessl, D., Goodlin-Jones, B., Ferranti, J., Bacalman, S., Barbato, I., et al. (2008). Autism profiles of males with fragile X syndrome. American Journal of Mental Retardation, 113(6), 427–438. PubMedCrossRef

Hatton, D., Bailey, D. B., Roberts, J., Skinner, M., Mayher, L., Duffee Clark, R., et al. (2000). Early intervention services for young boys with fragile X syndrome. Journal of Early Intervention, 23(4), 235–251. CrossRef

Hatton, D. D., Sideris, J., Skinner, M., Mankowski, J., Bailey, D. B., Jr, Roberts, J. E., et al. (2006). Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP. American Journal of Medical Genetics, Part A, 140(17), 1804–1813. CrossRef

Hecimovic, S., Tarnik, I. P., Baric, I., Cakarun, Z., & Pavelic, K. (2002). Screening for fragile X syndrome: Results from a school for mentally retarded children. Acta Paediatrica, 91(5), 535–539. PubMedCrossRef

Hertz-Picciotto, I., Croen, L. A., Hansen, R., Jones, C. R., van de Water, J., & Pessah, I. N. (2006). The CHARGE study: An epidemiologic investigation of genetic and environmental factors contributing to autism. Environmental Health Perspectives, 114(7), 1119–1125. PubMedCrossRef

Hessl, D., Tassone, F., Loesch, D. Z., Berry-Kravis, E., Leehey, M. A., Gane, L. W., et al. (2005). Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 139(1), 115–121. CrossRef

Iong, K., Tong, T., Gane, L., Sorensen, P., Berry-Kravis, E., Nguyen, D., Mu, Y., Skinner, D., Bailey, D., Hagerman, R., & Tassone, F. (2011). Newborn screening in fragile X syndrome: prevalence and allele distribution of the FMR1 gene. Paper presented at the American College Medical Genetics, Vancouver.

Jacquemont, S., Hagerman, R. J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J. A., et al. (2003). Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. American Journal of Human Genetics, 72(4), 869–878. PubMedCrossRef

Kau, A. S. M., Tierney, E., Bukelis, I., Stump, M. H., Kates, W. R., Trescher, W. H., et al. (2004). Social behavior profile in young males with fragile X syndrome: Characteristics and specificity. American Journal of Medical Genetics, 126A, 9–17. PubMedCrossRef

Lachiewicz, A. M., & Dawson, D. V. (1994). Behavior problems of young girls with fragile X syndrome: Factor scores on the Conners’ Parent’s Questionnaire. American Journal of Medical Genetics, 51(4), 364–369. PubMedCrossRef

Lewis, P., Abbeduto, L., Murphy, M., Richmond, E., Giles, N., Bruno, L., et al. (2006). Cognitive, language and social-cognitive skills of individuals with fragile X syndrome with and without autism. Journal of Intellectual Disability Research, 50(Pt 7), 532–545. PubMedCrossRef

Loesch, D. Z., Bui, Q. M., Dissanayake, C., Clifford, S., Gould, E., Bulhak-Paterson, D., et al. (2007). Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neuroscience and Biobehavioral Reviews, 31(3), 315–326. PubMedCrossRef

Loesch, D. Z., Godler, D. E., Khaniani, M., Gould, E., Gehling, F., Dissanayake, C., et al. (2009). Linking the FMR1 alleles with small CGG expansions with neurodevelopmental disorders: Preliminary data suggest an involvement of epigenetic mechanisms. American Journal of Medical Genetics, Part A, 149A(10), 2306–2310. CrossRef

Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Jr, Leventhal, B. L., DiLavore, P. C., et al. (2000). The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorder, 30(3), 205–223. CrossRef

Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659–685. PubMedCrossRef

Maddalena, A., Richards, C. S., McGinniss, M. J., Brothman, A., Desnick, R. J., Grier, R. E., et al. (2001). Technical standards and guidelines for fragile X: The first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genetic Medicine, 3(3), 200–205. CrossRef

Major, T., Culjkovic, B., Stojkovic, O., Gucscekic, M., Lakic, A., & Romac, S. (2003). Prevalence of the fragile X syndrome in Yugoslav patients with non-specific mental retardation. Journal of Neurogenetics, 17(2–3), 223–230. PubMed

Mazzocco, M. M., Kates, W. R., Baumgardner, T. L., Freund, L. S., & Reiss, A. L. (1997). Autistic behaviors among girls with fragile X syndrome. Journal of Autism and Developmental Disorder, 27(4), 415–435. CrossRef

Mila, M., Sanchez, A., Badenas, C., Brun, C., Jimenez, D., Villa, M. P., et al. (1997). Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: Identification of a case of FRAXE-associated mental retardation. Human Genetics, 100, 503–507. PubMedCrossRef

Miller, L. J., McIntosh, D. N., McGrath, J., Shyu, V., Lampe, M., Taylor, A. K., et al. (1999). Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: A preliminary report. American Journal of Medical Genetics, 83(4), 268–279. PubMedCrossRef

Mullen, E. M. (1995). Mullen Scales of Early Learning. Circle Pines: American Guidance Service.

Murray, A., Youings, S., Dennis, N., Latsky, L., Linehan, P., McKechnie, N., et al. (1996). Population screening at the FRAXA and FRAXE loci: Molecular analyses of boys with learning difficulties and their mothers. Human Molecular Genetics, 5(6), 727–735. PubMedCrossRef

Pandey, U. B., Phadke, S., & Mittal, B. (2002). Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation. Genetic Testing, 6(4), 335–339. PubMedCrossRef

Patsalis, P. C., Sismani, C., Hettinger, J. A., Boumba, I., Georgiou, I., Stylianidou, G., et al. (1999). Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability. American Journal of Medical Genetics, 84(3), 184–190. PubMedCrossRef

Pieretti, M., Zhang, F. P., Fu, Y. H., Warren, S. T., Oostra, B. A., Caskey, C. T., et al. (1991). Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66(4), 817–822. PubMedCrossRef

Pouya, A. R., Abedini, S. S., Mansoorian, N., Behjati, F., Nikzat, N., Mohseni, M., et al. (2009). Fragile X syndrome screening of families with consanguineous and non-consanguineous parents in the Iranian population. European Journal of Medical Genetics, 52(4), 170–173. PubMedCrossRef

Reddy, K. S. (2005). Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Medical Genetics, 6(1), 3. PubMedCrossRef

Roberts, J. E., Bailey, D. B., Jr, Mankowski, J., Ford, A., Sideris, J., Weisenfeld, L. A., et al. (2009). Mood and anxiety disorders in females with the FMR1 premutation. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics, 150B(1), 130–139. CrossRef

Rogers, S. J., Wehner, E. A., & Hagerman, R. J. (2001). The behavioral phenotype in fragile X: Symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. Journal of Developmental and Behavioral Pediatrics, 22(6), 409–417. PubMedCrossRef

Rousseau, F., Rouillard, P., Morel, M. L., Khandjian, E. W., & Morgan, K. (1995). Prevalence of carriers of premutation-size alleles of the FMRI gene—and implications for the population genetics of the fragile X syndrome. American Journal of Human Genetics, 57(5), 1006–1018. PubMed

Rutter, M., Bailey, A., Berument, S. K., Lord, C., & Pickles, A. (2003). Social Communication Questionnaire (SCQ). Los Angeles: Western Psychological Services.

Schaefer, G. B., & Lutz, R. E. (2006). Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genetic Medicine, 8(9), 549–556.

Sharma, D., Gupta, M., & Thelma, B. K. (2001). Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population. Genetic Epidemiology, 20(1), 129–144. PubMedCrossRef

Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics (Seminars in Medical Genetics), 97(3), 189–194. CrossRef

Sparrow, S. S., Balla, D. A., & Cicchetti, D. V. (1984). Vineland Adaptive Behavior Scales Survey Form Manual. Circle Pines: American Guidance Service.

Sudhalter, V., Cohen, I. L., Silverman, W., & Wolf-Schein, E. G. (1990). Conversational analyses of males with fragile X, Down syndrome, and autism: Comparison of the emergence of deviant language. American Journal of Mental Retardation, 94(4), 431–441. PubMed

Sullivan, A. K., Crawford, D. C., Scott, E. H., Leslie, M. L., & Sherman, S. L. (2002). Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. American Journal of Human Genetics, 70(6), 1532–1544. PubMedCrossRef

Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J., et al. (2005). Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction, 20(2), 402–412. PubMedCrossRef

Syrrou, M., Georgiou, I., Grigoriadou, M., Petersen, M. B., Kitsiou, S., Pagoulatos, G., et al. (1998). FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population. Genetic Epidemiology, 15(1), 103–109. PubMedCrossRef

Tassone, F., Hagerman, R. J., Chamberlain, W. D., & Hagerman, P. J. (2000). Transcription of the FMR1 gene in individuals with fragile X syndrome. American Journal of Medical Genetics (Seminars in Medical Genetics), 97(3), 195–203. CrossRef

Tassone, F., Pan, R., Amiri, K., Taylor, A. K., & Hagerman, P. J. (2008). A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. Journal of Molecular Diagnostics, 10(1), 43–49. PubMedCrossRef

Toledano-Alhadef, H., Basel-Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., et al. (2001). Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. American Journal of Human Genetics, 69(2), 351–360. PubMedCrossRef

Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65(5), 905–914. PubMedCrossRef

Watson, M. S., Breg, W. R., Hobbins, J. C., & Mahoney, M. J. (1984). Cytogenetic diagnosis using midtrimester fetal blood samples: Application to suspected mosaicism and other diagnostic problems. American Journal of Medical Genetics, 19(4), 805–813. PubMedCrossRef

Wittenberger, M. D., Hagerman, R. J., Sherman, S. L., McConkie-Rosell, A., Welt, C. K., Rebar, R. W., et al. (2007). The FMR1 premutation and reproduction. Fertility and Sterility, 87(3), 456–465. PubMedCrossRef

Yrigollen, C. M., Durbin-Johnson, B., Gane, L., Nelson, D. L., Hagerman, R., Hagerman, P. J., & Tassone, F. (2012). AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genetics in Medicine. doi: 10.1038/gim.2012.34

Yrigollen, C. M., Tassone, F., & Durbin-Johnson, B. (2011). The role of AGG interruptions in the transcription of FMR1 premutation alleles. PLoS One, 6(7), e21728. PubMedCrossRef

Yu, S., Pritchard, M., Kremer, E., Lynch, M., Nancarrow, J., Baker, E., et al. (1991). Fragile X genotype characterized by an unstable region of DNA. Science, 252(5010), 1179–1181. CrossRef

Yuhas, J., Walichiewicz, P., Pan, R., Zhang, W., Casillas, E. M., Hagerman, R. J., et al. (2009). High-risk fragile x screening in Guatemala: Use of a new blood spot polymerase chain reaction technique. Genetic Testing and Molecular Biomarkers, 13(6), 855–859. PubMedCrossRef

Titel: Identification of Expanded Alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) Study
Auteurs:: Flora Tassone
Nimrah S. Choudhary
Federica Tassone
Blythe Durbin-Johnson
Robin Hansen
Irva Hertz-Picciotto
Isaac Pessah
Publicatiedatum: 01-03-2013
DOI: https://doi.org/10.1007/s10803-012-1580-2
Uitgeverij: Springer US
Tijdschrift: Journal of Autism and Developmental Disorders
Uitgave 3/2013
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Tip

Swipe om te navigeren naar een ander artikel

Electronic supplementary material

Abstract

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Andere artikelen Uitgave 3/2013

E. K. Farran and A. Karmiloff-Smith: Neurodevelopmental Disorders Across the Lifespan: A Neuroconstructivist Approach

Prevalence of Psychotropic Drug Use in Adults with Intellectual Disability: Positive and Negative Findings from a Large Scale Study

The Effects of Covert Audio Coaching on Teaching Clerical Skills to Adolescents with Autism Spectrum Disorder

A Parent-Mediated Intervention to Increase Responsive Parental Behaviors and Child Communication in Children with ASD: A Randomized Clinical Trial

Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials

Effects of Computer Simulation Training on In Vivo Discrete Trial Teaching